skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer

Preferred term

alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-glcnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1->1')-cer  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • 0

formula

  • C57H99N2O32R

mass

  • 1324.39020

monoisotopicmass

  • 1323.61809

smiles

  • CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]5O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC([*])=O

subset

  • 3_STAR

synonym EXACT

  • N-[(2S,3R,4E)-1-{[alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:62361

Download this concept: